Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01917240 · ClinicalTrials.gov registry record · Phase 4
Sequential vs. Monophasic Media Impact Trial (SuMMIT)
A Phase 4 study, sponsored by Reproductive Medicine Associates of New Jersey.
- Completed
- Registry status
- Phase 4
- Development phase
- 200
- Enrollment target
NCT01917240 is a Phase 4 study that has completed, run by Reproductive Medicine Associates of New Jersey. The registered enrollment target is 200 participants.
The verdict
NCT01917240, a Phase 4 study, has completed, sponsored by Reproductive Medicine Associates of New Jersey.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 200 participants
- Enrollment target
Study Summary
To evaluate the impact of two FDA approved culture media on potential of human embryos resulting from IVF (sequential \& monophasic media). Half of each patient's embryos will be randomly assigned to grow in monophasic media \& the other half in sequential media. All embryos will undergo Comprehensive Chromosome Screening (CCS) \& the best euploid embryo from each group will be transferred resulting in a double embryo transfer (DET). If there are only euploid embryos from one group, patient will have single embryo transfer (SET)(fresh or frozen).
Interventions
- OTHER Comprehensive Chromosome Screening
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2013-07 |
| Est. Completion | 2016-05 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01917240
The ClinicalTrials.gov registry entry for NCT01917240 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 200 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Reproductive Medicine Associates of New Jersey, which has 51 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Comprehensive Chromosome Screening is the first listed.
NCT01917240 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01917240 about?
NCT01917240 is a clinical study titled "Sequential vs. Monophasic Media Impact Trial (SuMMIT)". To evaluate the impact of two FDA approved culture media on potential of human embryos resulting from IVF (sequential \& monophasic media). Half of each patient's embryos will be randomly assigned to grow in monophasic media \& the other half in sequential media. All embryos will undergo Comprehensi...
What is the current status of trial NCT01917240?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 200 participants. The study started on 2013-07. Estimated completion is 2016-05.
What interventions are being tested in trial NCT01917240?
The interventions under investigation include: Comprehensive Chromosome Screening (OTHER).
Who is sponsoring clinical trial NCT01917240?
This trial is sponsored by Reproductive Medicine Associates of New Jersey, which has 51 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.